mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.8 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |